Shionogi's ROE FY 2018-2021

Published by
Catharina Klein,
Oct 16, 2024

In fiscal year 2021, the return on equity of Shionogi stood at 12.5 percent. The return on equity declined by 1.4 percent compared to the previous fiscal year.

Return on equity of Shionogi Co., Ltd. from fiscal year 2018 to 2021

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

October 2024

Region

Japan, APAC

Survey time period

fiscal year 2018 to 2021; the Japanese fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Supplementary notes

100 Japanese yen equal 0.69 U.S. dollars or 0.62 euros as of October 2024.

Figures have been rounded.

ROE = Profit attributable to owners of parent/(Shareholders’ equity + accumulated other comprehensive income)

Release date is date of access.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Medication and medical treatments in Japan "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Medication and medical treatments in Japan

Overview

6

Production value of medication

6

Production value of medication by category

5

OTC and prescription drugs

7

Quasi drugs

4

Health supplements

5

Alternative medicine

5

Further Content: You might find this interesting as well

Topics

SanofiGlobal pharmaceutical industryTop pharmaceutical drugsPfizerNovartis
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.